Add to ORKGThe present invention relates to gene sets, the expression levels of which are useful for classifying colorectal tumors and predicting disease-free prognosis and response of patients to specific therapies that are either novel or currently available in the clinics for colorectal cancer patients
<div><p>A considerable portion of patients with colorectal cancer have a high risk of disease recurr...
Colon adenocarcinoma is the most common type of colorectal cancer. The prognosis of advanced colorec...
Introduction: Colorectal cancer is the third most common cancer in the world, a small fraction of wh...
The invention provides a molecular marker set that can be used for prognosis of colorectal cancer in...
The molecular genetics of colorectal cancers (CRCs) is among the best understood of common human can...
Colorectal cancer (CRC) is a major cause of cancer mortality. Whereas some patients respond well to ...
Purpose This study aims to develop a robust gene expression classifier that can predict disease rela...
We used digital long serial analysis of gene expression to discover gene expression differences betw...
Colorectal cancer is a heterogeneous disease that manifests through diverse clinical scenarios. Duri...
Disclosed is a set of genes differentially expressed in chemotherapy and radiation resistant tumors ...
Cancers of the colon and rectum, which rank among the most frequent human tumors, are currently trea...
Colorectal cancer has been characterized as a genetically heterogeneous disease, with a large divers...
A considerable portion of patients with colorectal cancer have a high risk of disease recurrence aft...
Journal articleDespite developments in diagnosis and treatment, 20% of colorectal cancer (CRC) patie...
Colorectal cancer is a heterogeneous disease. We are unable to predict which colorectal cancer patie...
<div><p>A considerable portion of patients with colorectal cancer have a high risk of disease recurr...
Colon adenocarcinoma is the most common type of colorectal cancer. The prognosis of advanced colorec...
Introduction: Colorectal cancer is the third most common cancer in the world, a small fraction of wh...
The invention provides a molecular marker set that can be used for prognosis of colorectal cancer in...
The molecular genetics of colorectal cancers (CRCs) is among the best understood of common human can...
Colorectal cancer (CRC) is a major cause of cancer mortality. Whereas some patients respond well to ...
Purpose This study aims to develop a robust gene expression classifier that can predict disease rela...
We used digital long serial analysis of gene expression to discover gene expression differences betw...
Colorectal cancer is a heterogeneous disease that manifests through diverse clinical scenarios. Duri...
Disclosed is a set of genes differentially expressed in chemotherapy and radiation resistant tumors ...
Cancers of the colon and rectum, which rank among the most frequent human tumors, are currently trea...
Colorectal cancer has been characterized as a genetically heterogeneous disease, with a large divers...
A considerable portion of patients with colorectal cancer have a high risk of disease recurrence aft...
Journal articleDespite developments in diagnosis and treatment, 20% of colorectal cancer (CRC) patie...
Colorectal cancer is a heterogeneous disease. We are unable to predict which colorectal cancer patie...
<div><p>A considerable portion of patients with colorectal cancer have a high risk of disease recurr...
Colon adenocarcinoma is the most common type of colorectal cancer. The prognosis of advanced colorec...
Introduction: Colorectal cancer is the third most common cancer in the world, a small fraction of wh...